Riskpilot← Back to searchSign inGet full accesszoltangynecare AB
ABActiveOrg 5591388318Södra Vägen 30Hospital activities · NACE 8610Est. 20171 employees
Revenue 2025
SEK 1,9M
+18% vs 2024
EBITDA margin
31.4%
-31% vs 2024
Equity ratio
57.4%
Financial strength
Net profit 2025
SEK 513K
-26% vs 2024
| Revenue | SEK 1,9M | +18% |
| EBITDA | SEK 599K | -31% |
| Net profit | SEK 513K | -26% |
| Total assets | SEK 1,9M | +27% |
| Equity | SEK 1,1M | +32% |
| Employees | 1 | — |
Legal name
zoltangynecare AB
Org number
5591388318
Legal form
Aktiebolag
NACE code
8610 · Hospital activities
Founded
12 december 2017
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Sjukvård, Fritidskonsulting,Postorderhandel och detaljhandel på Internet med sport- och fritidsutrustning Partihandel med sport- och fritidsartiklar, bilhandel
Address
Södra Vägen 30
Email
czankzoltan@yahoo.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 153 | 113 | 1 622 | 1 909 |
| Staff expenses | — | — | — | −637 | −1 177 |
| EBITDA | −22 | 125 | 74 | 874 | 599 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | −22 | 125 | 74 | 874 | 599 |
| Net financials | −2 | −0 | 2 | 2 | −12 |
| Profit before tax | 1 | 125 | 76 | 876 | 651 |
| Tax | 1 | −26 | −16 | −181 | −138 |
| Net profit | 2 | 99 | 60 | 695 | 513 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 177 | 324 | 286 | 1 500 | 1 910 |
| Equity | 101 | 200 | 199 | 834 | 1 097 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 12 | 60 | 23 | 602 | 813 |
| Total debt | 12 | 60 | 23 | 602 | 813 |
EBITDA margin
31.4%
This company
15.8%
Market median
+99% vs market
20212025
Equity ratio
57.4%
This company
38.2%
Market median
+50% vs market
20212025
Return on equity
46.8%
This company
18.4%
Market median
+154% vs market
20212025
Net profit margin
26.9%
This company
8.1%
Market median
+232% vs market
20212025
Asset turnover
1.00×
This company
1.12×
Market median
+11% vs market
20212025
Debt / equity
0.74×
This company
0.62×
Market median
+19% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of zoltangynecare AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Zoltan Czank | Board of Directors | 0 companies |
| Attila-Zsolt Vass | Deputy Board Member | 0 companies |